Hypoparathyroidism historical perspective: Difference between revisions

Jump to navigation Jump to search
Line 17: Line 17:
* In 1880, Ivar Sandström, a Swedish anatomist, described [[parathyroids]] in human following 50 autopsies. He found two [[parathyroid]] glands bilaterally in 43 out of 50 autopsies.<ref name="pmid25913489">{{cite journal |vauthors=Johansson H |title=The Uppsala anatomist Ivar Sandström and the parathyroid gland |journal=Ups. J. Med. Sci. |volume=120 |issue=2 |pages=72–7 |year=2015 |pmid=25913489 |pmc=4463479 |doi=10.3109/03009734.2015.1027426 |url=}}</ref>
* In 1880, Ivar Sandström, a Swedish anatomist, described [[parathyroids]] in human following 50 autopsies. He found two [[parathyroid]] glands bilaterally in 43 out of 50 autopsies.<ref name="pmid25913489">{{cite journal |vauthors=Johansson H |title=The Uppsala anatomist Ivar Sandström and the parathyroid gland |journal=Ups. J. Med. Sci. |volume=120 |issue=2 |pages=72–7 |year=2015 |pmid=25913489 |pmc=4463479 |doi=10.3109/03009734.2015.1027426 |url=}}</ref>
* In 1909, William George MacCallum and Carl Voegtlin, demonstrated association between [[parathyroid gland]], [[calcium]], and [[tetany]].<ref name="pmid19867238">{{cite journal |vauthors=Maccallum WG, Voegtlin C |title=ON THE RELATION OF TETANY TO THE PARATHYROID GLANDS AND TO CALCIUM METABOLISM |journal=J. Exp. Med. |volume=11 |issue=1 |pages=118–51 |year=1909 |pmid=19867238 |pmc=2124703 |doi= |url=}}</ref>
* In 1909, William George MacCallum and Carl Voegtlin, demonstrated association between [[parathyroid gland]], [[calcium]], and [[tetany]].<ref name="pmid19867238">{{cite journal |vauthors=Maccallum WG, Voegtlin C |title=ON THE RELATION OF TETANY TO THE PARATHYROID GLANDS AND TO CALCIUM METABOLISM |journal=J. Exp. Med. |volume=11 |issue=1 |pages=118–51 |year=1909 |pmid=19867238 |pmc=2124703 |doi= |url=}}</ref>
* In  1942,  
* In  1942, Albright et. al. first described the term pseudohypoparathyroidism. It is an example of Seabright-Bantam syndrome. In pseudohypoparathyroidism hypocalcemia and hyperphosphatemia is resistant to parathyroid hormone administration.<ref>{{cite journal |vauthors=Albright F, Burnett CH, Smith PH, Parson |date=1942 |title=Pseudohypoparathyroidism- An example of ‘Seabright-Bantam syndrome’ |url= |journal= Endocrinology |volume=30 |issue= |pages=922–32 |doi= |access-date= }}</ref>
* In 1959, Howard Rasmussen and Lyman C. Craig at the Rockefeller Institute for Medical Research purified [[parathyroid hormone]].<ref name="RasmussenCraig1959">{{cite journal|last1=Rasmussen|first1=Howard|last2=Craig|first2=Lyman C.|title=PURIFICATION OF PARATHYROID HORMONE BY USE OF COUNTERCURRENT DISTRIBUTION|journal=Journal of the American Chemical Society|volume=81|issue=18|year=1959|pages=5003–5003|issn=0002-7863|doi=10.1021/ja01527a066}}</ref> They also isolated the active [[polypeptide]] (parathormone B) from bovine [[parathyroid gland]] and gave its tentative formula in 1961.<ref>{{Cite journal||last1=Rasmussen|first1=Howard|last2=Craig|first2=Lyman C.|title = Isolation of a Parathyroid Polypeptide from Acetic Acid Extracts of Bovine Parathyroid Glands|volume = 236| number = 4|pages = 1083-1086|year = 1961|URL = http://www.jbc.org/content/236/4/1083.short|journal = {Journal of Biological Chemistry}}</ref>
* In 1959, Howard Rasmussen and Lyman C. Craig at the Rockefeller Institute for Medical Research purified [[parathyroid hormone]].<ref name="RasmussenCraig1959">{{cite journal|last1=Rasmussen|first1=Howard|last2=Craig|first2=Lyman C.|title=PURIFICATION OF PARATHYROID HORMONE BY USE OF COUNTERCURRENT DISTRIBUTION|journal=Journal of the American Chemical Society|volume=81|issue=18|year=1959|pages=5003–5003|issn=0002-7863|doi=10.1021/ja01527a066}}</ref> They also isolated the active [[polypeptide]] (parathormone B) from bovine [[parathyroid gland]] and gave its tentative formula in 1961.<ref>{{Cite journal||last1=Rasmussen|first1=Howard|last2=Craig|first2=Lyman C.|title = Isolation of a Parathyroid Polypeptide from Acetic Acid Extracts of Bovine Parathyroid Glands|volume = 236| number = 4|pages = 1083-1086|year = 1961|URL = http://www.jbc.org/content/236/4/1083.short|journal = {Journal of Biological Chemistry}}</ref>



Revision as of 13:54, 18 September 2017

Hypoparathyroidism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypoparathyroidism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypoparathyroidism historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypoparathyroidism historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypoparathyroidism historical perspective

CDC on Hypoparathyroidism historical perspective

Hypoparathyroidism historical perspective in the news

Blogs on Hypoparathyroidism historical perspective

Directions to Hospitals Treating Hypoparathyroidism

Risk calculators and risk factors for Hypoparathyroidism historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Discovery

  • [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
  • The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
  • In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
  • In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
  • In 1852, Sir Richard Owen, Hunterian Professor and Conservator of the Museum in the Royal College of Surgeons of England, described parathyroids in rhinoceros.[1]
  • In 1880, Ivar Sandström, a Swedish anatomist, described parathyroids in human following 50 autopsies. He found two parathyroid glands bilaterally in 43 out of 50 autopsies.[2]
  • In 1909, William George MacCallum and Carl Voegtlin, demonstrated association between parathyroid gland, calcium, and tetany.[3]
  • In 1942, Albright et. al. first described the term pseudohypoparathyroidism. It is an example of Seabright-Bantam syndrome. In pseudohypoparathyroidism hypocalcemia and hyperphosphatemia is resistant to parathyroid hormone administration.[4]
  • In 1959, Howard Rasmussen and Lyman C. Craig at the Rockefeller Institute for Medical Research purified parathyroid hormone.[5] They also isolated the active polypeptide (parathormone B) from bovine parathyroid gland and gave its tentative formula in 1961.[6]

Outbreaks

  • There have been several outbreaks of [disease name], which are summarized below:

Landmark Events in the Development of Treatment Strategies

  • In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].
  • In 1925, James Bertram Collip along with Douglous B Leitch treated tetany with the help of parathyroid extract. They names the extract as Parathyrin.[7]

Impact on Cultural History

Famous Cases

References

  1. Modarai B, Sawyer A, Ellis H (2004). "The glands of Owen". J R Soc Med. 97 (10): 494–5. doi:10.1258/jrsm.97.10.494. PMC 1079622. PMID 15459265.
  2. Johansson H (2015). "The Uppsala anatomist Ivar Sandström and the parathyroid gland". Ups. J. Med. Sci. 120 (2): 72–7. doi:10.3109/03009734.2015.1027426. PMC 4463479. PMID 25913489.
  3. Maccallum WG, Voegtlin C (1909). "ON THE RELATION OF TETANY TO THE PARATHYROID GLANDS AND TO CALCIUM METABOLISM". J. Exp. Med. 11 (1): 118–51. PMC 2124703. PMID 19867238.
  4. Albright F, Burnett CH, Smith PH, Parson (1942). "Pseudohypoparathyroidism- An example of 'Seabright-Bantam syndrome'". Endocrinology. 30: 922–32.
  5. Rasmussen, Howard; Craig, Lyman C. (1959). "PURIFICATION OF PARATHYROID HORMONE BY USE OF COUNTERCURRENT DISTRIBUTION". Journal of the American Chemical Society. 81 (18): 5003–5003. doi:10.1021/ja01527a066. ISSN 0002-7863.
  6. Rasmussen, Howard; Craig, Lyman C. (1961). "Isolation of a Parathyroid Polypeptide from Acetic Acid Extracts of Bovine Parathyroid Glands". {Journal of Biological Chemistry. 236 (4): 1083–1086.
  7. Collip JB, Leitch DB (1925). "A Case of Tetany treated with Parathyrin". Can Med Assoc J. 15 (1): 59–60. PMC 1707993. PMID 20315252.

Template:WH Template:WS